Back to Search
DVORAH HOLTZMAN, MD
MD
Internal Medicine Physician
NPI: 1700019320IndividualAccepts Medicare
Specialties, Licenses & Credentials
Internal Medicine PhysicianPrimary
Internal Medicine
Code: 207R00000X
06-248901(NY)
Education
ALBERT EINSTEIN COLLEGE OF MEDICINE OF YESHIVA UNIVERSITY
Class of 2005
Research & Publications (20)
Prospective case series on the effects of lumbosacral manipulation on dysmenorrhea.
PMID 18394502·J Manipulative Physiol Ther·2008
3-trial
Nutritional counseling in the chiropractic practice: a survey of New York practitioners.
PMID 19674691·J Chiropr Med·2007
8-other
Apolipoprotein E mediates sulfatide depletion in animal models of Alzheimer's disease.
PMID 18762354·Neurobiol Aging·2010
7-preclinical
A gamma-secretase inhibitor decreases amyloid-beta production in the central nervous system.
PMID 19360898·Ann Neurol·2009
2-rct
Neuroprotective natural antibodies to assemblies of amyloidogenic peptides decrease with normal aging and advancing Alzheimer's disease.
PMID 19581601·Proc Natl Acad Sci U S A·2009
7-preclinical
Cerebrospinal fluid biomarkers and rate of cognitive decline in very mild dementia of the Alzheimer type.
PMID 19433664·Arch Neurol·2009
8-other
Alzheimer's disease risk variants show association with cerebrospinal fluid amyloid beta.
PMID 18813964·Neurogenetics·2009
8-other
Novel pentameric thiophene derivatives for in vitro and in vivo optical imaging of a plethora of protein aggregates in cerebral amyloidoses.
PMID 19624097·ACS Chem Biol·2009
7-preclinical
Lack of X-linked inhibitor of apoptosis protein leads to increased apoptosis and tissue loss following neonatal brain injury.
PMID 19570023·ASN Neuro·2009
4-observational
Caffeine suppresses amyloid-beta levels in plasma and brain of Alzheimer's disease transgenic mice.
PMID 19581723·J Alzheimers Dis·2009
7-preclinical
Critical issues for successful immunotherapy in Alzheimer's disease: development of biomarkers and methods for early detection and intervention.
PMID 19355934·CNS Neurol Disord Drug Targets·2009
6-review
Microglia mediate the clearance of soluble Abeta through fluid phase macropinocytosis.
PMID 19339619·J Neurosci·2009
7-preclinical
Decreased cerebrospinal fluid Abeta(42) correlates with brain atrophy in cognitively normal elderly.
PMID 19260027·Ann Neurol·2009
8-other
Effects of voluntary and forced exercise on plaque deposition, hippocampal volume, and behavior in the Tg2576 mouse model of Alzheimer's disease.
PMID 19524672·Neurobiol Dis·2009
7-preclinical
The influence of needle exchange programs on injection risk behaviors and infection with hepatitis C virus among young injection drug users in select cities in the United States, 1994-2004.
PMID 19410600·Prev Med·2009
4-observational
Cerebrovascular dysfunction in amyloid precursor protein transgenic mice: contribution of soluble and insoluble amyloid-beta peptide, partial restoration via gamma-secretase inhibition.
PMID 19074028·J Neurosci·2008
7-preclinical
apoE isoform-specific disruption of amyloid beta peptide clearance from mouse brain.
PMID 19033669·J Clin Invest·2008
7-preclinical
The low density lipoprotein receptor-related protein 1 mediates uptake of amyloid beta peptides in an in vitro model of the blood-brain barrier cells.
PMID 18940800·J Biol Chem·2008
7-preclinical
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 158 E 84TH ST
NEW YORK, NY 10028 - Phone
- (212) 535-6340
Quick Facts
- NPI
- 1700019320
- Entity Type
- Individual
- Gender
- Female
- Medicare
- Accepted
- Specialties
- 1
- Locations
- 1
- Years in Practice
- 21
- Publications
- 20
Are you this provider?
Claim Your Profile